According to Medifast's latest financial reports the company's current EPS (TTM) is $12.21. In 2022 the company made an earnings per share (EPS) of $12.81 a decrease over its 2021 EPS that were of $14.02.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $12.21 | -4.68% |
2022 | $12.81 | -8.63% |
2021 | $14.02 | 60.41% |
2020 | $8.74 | 32.02% |
2019 | $6.62 | 42.06% |
2018 | $4.66 | 100% |
2017 | $2.33 | 54.3% |
2016 | $1.51 | -9.04% |
2015 | $1.66 | 66% |
2014 | $1.00 | -42.53% |
2013 | $1.74 | 50% |
2012 | $1.16 | -12.12% |
2011 | $1.32 | -5.71% |
2010 | $1.40 | 66.67% |
2009 | $0.84 | 127.03% |
2008 | $0.37 | 23.33% |
2007 | $0.30 | -18.92% |
2006 | $0.37 | 68.18% |
2005 | $0.22 | 37.5% |
2004 | $0.16 | -36% |
2003 | $0.25 | -30.56% |
2002 | $0.36 | 350% |
2001 | $0.08000 | -57.89% |
2000 | $0.19 |